Contact CFFC

Aug

Clinical Trial Alert – August 2020

Cystic Fibrosis Foundation issued the following clinical trial alert on August 24, 2020.

Study to evaluate the effects of CFTR modulators in infants and young children (BEGIN)

Status: Enroling

Description: This two-part observational study will look at the effects of CFTR modulators on growth in infants and young children with CF. These drugs are intended to help CFTR protein function closer to normal.

Age: 0 Years to 6 Years

Mutation: No Mutation Requirement

Fev1% Predicted: No FEV1 Limit

Number of Visits: 6

Length of Participation: 3 years

ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT04509050


Comments are closed.